The National Institutes of Health and the National Cancer Institute have awarded a $1.2 million grant to a University of Arkansas for Medical Sciences (UAMS) researcher to develop treatments for leukemia patients.
Hong-yu Li, Ph.D. has received the $1,265,834 grant, which will fund five years of research, in which Li will develop treatments for acute myeloid leukemia patients.In addition to serving as a researcher with the Winthrop P. Rockefeller Cancer Institute at UAMS, Li serves as a professor at College of Pharmacy in the Pharmaceutics Department and leads the Developmental Therapeutics research program.
In his research, Li concentrates on cancers of the brain, breast, stomach and intestines, head and neck, and skin as well as leukemia, lymphoma and myeloma.
“I am so pleased that Dr. Li’s research is being recognized and supported in this way by the National Institutes of Health and the National Cancer Institute,” Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute, said in a statement. “The results of his work, made possible by this grant, could be life-altering for some of our acute myeloid leukemia patients.”
Li and his research team will be optimizing experimental drugs in this study, using tissue samples from acute myeloid leukemia patients. The goal is to improve the effectiveness of existing drug therapies.
“This research is important to the public health because acute myeloid leukemia has a major impact on our society in the patient’s suffering and shortened life and the financial burdens it creates,” Li said.